Quantcast

Latest Daiichi Sankyo Stories

2014-09-04 12:28:12

LONDON, Sept. 4, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Antibody Drug Conjugates: Contract Manufacturing Market, 2014-2024https://www.reportbuyer.com/product/2016141/Antibody-Drug-Conjugates-Contract-Manufacturing-Market-2014-2024.html INTRODUCTIONThe concept of Antibody drug conjugates (ADCs) is simple - a cytotoxic / chemotherapy drug is delivered to the target tissue through linking it with a monoclonal antibody. However, the practical...

2014-09-02 12:29:29

BARCELONA, Spain, September 2, 2014 /PRNewswire/ -- Registry provides new insights into AF treatment decisions, including patients' quality of life and treatment satisfaction[1],[2] (Photo: http://photos.prnewswire.com/prnh/20140902/703596 ) ESC Congress 2014, 02 September 2014, Barcelona, Spain: Daiichi Sankyo today announced one year results of the PREvention oF thromboembolic events-European Registry in Atrial Fibrillation (PREFER...

2014-08-06 20:23:58

Daiichi Sankyo and Charleston Laboratories will collaborate on development and commercialization; Charleston will supply all products and retain an option to co-promote in the United States TOKYO, PARSIPPANY, N.J. and JUPITER, Fla., Aug. 6, 2014 /PRNewswire/ -- Daiichi Sankyo and Charleston Laboratories, Inc., through its wholly owned subsidiary LOCL Pharma, Inc., announced today that the parties have entered into a strategic collaboration for the development and U.S....

2014-07-19 23:03:05

Benicar Lawsuit News: According to the FDA, Benicar Is Associated With Severe Gastrointestinal Disorder Called Sprue-Like Enteropathy, Which Can Cause Chronic Diarrhea, Rapid Weight Loss, Vomiting, and Other Serious Health Problems. Columbus, OH (PRWEB) July 19, 2014 A Benicar lawsuit webpage has been launched by Wright & Schulte LLC to provide consumers with important information regarding a serious gastrointestinal disorder called sprue-like enteropathy that can sometimes accompany...

2014-06-27 23:07:56

Kristine Kraft of Schlichter, Bogard & Denton, LLP reports that a recent lawsuit alleges that the blood pressure medication Benicar® is linked to serious gastrointestinal injuries, such as enteropathy. St. Louis, MO (PRWEB) June 27, 2014 A new lawsuit has been filed in the Superior Court of New Jersey (Case No. ATL-L-506-14) against the drug manufacturer Daiichi Sankyo alleging severe gastrointestinal injuries as a result of ingesting the drug Benicar® (olmesartan...

2014-06-27 12:25:58

Receives first-to-file FDA approval, with 180-day marketing exclusivity for generic version in the treatment of hypertension and heart failure NEW BRUNSWICK, N.J., June 27, 2014 /PRNewswire/ -- Ohm Laboratories, Inc. (Ohm), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that Ohm has received approval from the U.S. Food and Drug Administration to manufacture and market Valsartan 40 mg, 80 mg, 160 mg, and 320 mg tablets on an exclusive basis....

2014-06-23 12:29:24

Coherus Advances Development as Part of Collaboration with Daiichi Sankyo and Baxter REDWOOD CITY, Calif., June 23, 2014 /PRNewswire/ -- Coherus BioSciences, Inc. announced the start of its Phase 3 trial of CHS-0214, an investigational etanercept biosimilar, in rheumatoid arthritis (RA). The Phase 3 trial is a randomized, double-blind, active-control, parallel-group, multicenter, global study in subjects with active RA who have demonstrated an inadequate response to methotrexate....

2014-06-10 16:27:52

LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Antibody Partnering Terms and Agreementshttp://www.reportbuyer.com/countries/north_america/usa/antibody_partnering_terms_agreements.html The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare companies.The Antibody Partnering Terms and...

2014-06-03 12:31:25

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:World OTC Pharmaceutical Market 2013-2023http://www.reportbuyer.com/pharma_healthcare/country_reports_pharmaceutical/world_otc_pharmaceutical_market_2012_2022.html Report DetailsDiscover the highest potential revenues in over-the-counter medicineWhat does the future hold for OTC medicines? Visiongain's report shows you potential revenues to 2023, assessing data, trends, opportunities and...

2014-05-28 12:31:30

LONDON, May 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Ovarian Cancer - Pipeline Review, H1 2014http://www.reportbuyer.com/pharma_healthcare/research_r_d/pipeline/ovarian_cancer.html Ovarian Cancer - Pipeline Review, H1 2014 SummaryGlobal Markets Direct's, 'Ovarian Cancer - Pipeline Review, H1 2014', provides an overview of the Ovarian Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic development...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.